Invention Grant
- Patent Title: Strain-promoted crosslinking of PEG-based hydrogels via copper-free cycloaddition
-
Application No.: US14418507Application Date: 2013-07-31
-
Publication No.: US09758671B2Publication Date: 2017-09-12
- Inventor: Matthew Becker , Robert A. Weiss
- Applicant: Matthew Becker , Robert A. Weiss
- Agency: Renner Kenner Greive Bobak Taylor Weber
- International Application: PCT/US2013/052911 WO 20130731
- International Announcement: WO2014/022501 WO 20140206
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C08L71/00 ; C08G65/325 ; C08G65/333 ; C08L71/02 ; C08L89/00 ; A61K9/06 ; A61K47/34

Abstract:
The present invention is directed to a covalently crosslinked hydrogel comprising the strain-promoted reaction product of an 8-member cycloalkyne functionalized polyalkylene glycol and a multi-arm glycerol exytholate triazide and methods for making them. Because the precursor materials can be manipulated without causing crosslinking, provided the strain threshold is not reached, these hydrogels permit mechanical control over when (and where) cross linking occurs and are easier to use than prior strain-activated or temperature-activated systems. These novel hydrogels do not require a catalyst to cross link, thus avoiding the biocompatibility problems common to many catalysts. Nor is the crosslinking process affected by the presence of catalysts or other substances, which have interfered with crosslinking in known strain induced hydrogels. Because of their crosslinking reaction kinetics, these novel hydrogels can encapsulate and transport highly sensitive cells and other biological additives and have no known toxic byproducts.
Public/Granted literature
- US20150183988A1 Strain-Promoted Crosslinking of PEG-based Hydrogels via Copper-Free Cycloaddition Public/Granted day:2015-07-02
Information query